Tag Archives: EPO

Obligation to submit search results to the EPO as of January 1, 2011

Submitting search results of priority applications to the EPO will become obligatory as of January 1, 2011 The Implementing Regulations of the European Patent Convention will change as of January 1, 2011, which apply to European patent applications and international … Continue reading

Posted in EP and UK Practice | Tagged , , , , , | Leave a comment

Sustained release fluvastatin formulations – The UK Court of Appeal opinion in Activis UK Limited v Novartis AG [2010] EWCA Civ 82

Post from Paul Cole Sometimes a decision as to obviousness hinges on a single short point. In Graham v John Deere, the tipping point testimony was during cross-examination of the witness for the patentee, when he said that the allegedly … Continue reading

Posted in Non-U.S. Practice | Tagged , , , | Leave a comment

END OF AN ERA – “SWISS-FORM” CLAIMS ARE OUT

The Enlarged Board of Appeal of the EPO issued a decision on February 19th (G02/08), that Swiss-form claims will no longer be permitted as a way to claim a “second medical use” of a bioactive agent – “The use of … Continue reading

Posted in Non-U.S. Practice | Tagged , , , | Leave a comment

Views of the EPO Enlarged Appeal Board in Treatment by surgery/MEDI-PHYSICS G 0001/07

Under what circumstances is injection a prohibited surgical method? Views of the EPO Enlarged Appeal Board in Treatment by surgery/MEDI-PHYSICS G 0001/07 .  Opinion From Paul Cole The present proceedings resulted from a referral in decision T 0992/03 relating to EP-A-1066537. … Continue reading

Posted in Non-U.S. Practice | Tagged , , , , | Leave a comment